Skip to main content
. Author manuscript; available in PMC: 2019 Aug 22.
Published in final edited form as: Curr Cancer Drug Targets. 2013 Jul;13(6):651–660. doi: 10.2174/15680096113139990040

Fig. (6). BA-TPQ activates the ZAK-MKK4-JNK cascade and ATF3 and DDIT3 in a breast cancer cell-dependent fashion.

Fig. (6).

MCF10A and MCF7 cells were incubated with DMSO or 0.5 μM BA-TPQ for 24 h. After the treatment, cell lysates were collected and Western blotting was performed to probe target protein expression as shown in the figure.